Cell Surface Marker Detection Industry is Led by North America

The total value of the cell surface marker detection market was USD 5,505.5 million in 2023, and it will touch USD 9,427.4 million by 2030, proceeding at a rate of 8.1 by the end of this decade. The industry is powered by the surge in the demand for precision medicine, increase in the acceptance of in vitro diagnostics, and tech progressions that enhance quantity and the rate of automation.

To learn more about this report: https://bit.ly/48GTZiF

The flow cytometry category had the leading share, of 35%, in 2023. This is mostly because this method can measure a large count of parameters in the same sample and collect info from millions of cells within a few seconds. Moreover, with this method, any non-consistency in an unvarying cell population is sensed, and it also eliminates all the dead cells or wreckage when offering the final data.

Cell surface markers are prevailing tools that aid in identifying high-risk patients precisely, enhancing the accuracy of the analysis, proceeding follow-up policies for people, approximating susceptibility to targeted therapy or immunotherapy, and prediction of prognostic results.

North America led the pack with a share of 55%, in 2023, credited to the increasing number of tech progressions, surging elderly populace, and growing occurrence of chronic ailments.

The U.S. is facing a demographic shift with the surge in the count of citizens aged 65 and more. This age group’s share in the total people will rise to approximately 24 % by 2060 from 15% in 2016. The ageing populace is more prone to chronic ailments, for example cardiac ailments, gastrointestinal issues, and cancer. Moreover, the U.S. ranks 5th in the age-standardized rates for all cancers.

Due to the increasing demand for precision medicines all over the globe, the demand for cell surface marker detection is on the rise.

Read More

Growth of Elderly People is Responsible for the Self-Monitoring Blood Glucose Devices Market Expansion

The self-monitoring blood glucose devices market made USD 25.3 billion in 2023, and it will advance at a rate of 9.7% by the end of this decade to touch USD 48.2 billion by 2030.

The industry growth has a lot to do with the growing occurrence of diabetes, increasing populace of elderly people, tech progressions, booming consciousness of diabetes care, increasing count of obese people, and favorable health insurance and repayment scenario.

Self-sugar-measuring gadgets are used in the monitoring of type 1 and 2 diabetes, and a few other ailments. Amongst all applications, type 2 diabetes had the largest share, of more than 50%, in 2023.

Type 2 diabetes is a common lifestyle ailment that can cause key health problems, chiefly in the blood vessels of the eyes, kidneys, and the nerves. Some of the key problems of the ailment are diabetic retinopathy and diabetic nephropathy.

Tech progressions in SMBG gadgets is a key trend in the self-monitoring blood glucose devices market, as the use of new-age devices decreases the time taken to test sugar levels as opposed to the traditional approaches used in labs. Furthermore, most of these devices are moveable and suitable to carry.

The unparalleled aging rate observed in the worldwide populace is a key contributor to the diabetes occurrence, and elderly people represent one of the fastest-growing segments of the diabetic populace. In emerging nations, the increase in the occurrence of chronic non-infectious illnesses, such as diabetes, cancer, and heart ailment, hints at alterations in the lifestyles and diets, along with aging.

Nearly 80% of the world’s older people will be living in emerging regions by 2050. Also, the number of people aged 60 years or more in emerging regions will surge to 1.7 billion by 2050.

It is because of the increasing prevalence of diabetes all over the world, the requirement for self-monitoring blood glucose devices is on the rise3. This will continue in the years to come as well.

Read More

Orthopedic Category Led the Medical X-Ray Film Processor Market

The medical X-ray film processor market will reach USD 1,238.5 million revenue by 2030, progressing at a rate of 3.2% by the end of this decade, rising considerably from USD 998.7 million in 2023. This is because of the increasing occurrence of cancer, orthopedic diseases, dental issues, and cardiac ailments, accompanied by the growing count of X-ray imaging procedures, mounting consciousness of early diagnosis, and growing healthcare spending.

To learn more about this report: https://bit.ly/3RYrabS

The fully automatic film processor led the industry with a share of 60%, in 2023, as a result of the high image eminence of these variants. Furthermore, as they need less processing time than the manual ones, additional films can be handled in a given period.

Also, the automated variant decreases the inconsistency in the film quality improved compared to manually processed films, since the solution temperature, processing time, and chemical replenishment are regulated automatically.

The orthopedic category had the largest medical X-ray film processor market share, on the basis of application. This is because of the widespread use of X-rays in numerous orthopedic practices to identify and monitor joint and bone conditions, for example dislocation, fractures, and arthritis. X-ray film processors are put to use for developing X-ray films required to produce diagnostic images, which aid healthcare specialists sense the condition and treat the patient consequently.

Therefore, the growing count of orthopedic cases will power the growth of the industry. For example, in the U.S., about 7 million orthopedic surgeries were done in 2021, which reflects a considerable volume of X-ray scans for diagnosis.

Stalwarts of the market have grown over the past by adding novel products to their portfolios and snowballing the occurrence of attainments and partnerships. In addition, these strategic associations and product introductions bring about a competitive edge.

For example, in March 2021, Fujifilm Corporation publicized that it has entered an arrangement with Hitachi Ltd. to obtain Hitachi’s diagnostic imaging business, so as to increase its healthcare business.

With the surge in the occurrence of chronic ailments and the increase in the elderly populace, the requirement for X-ray imaging procedures has increased in North America. Also, the industry is powered by the incidence of more than a few key players, obtainability of tech advanced products, and increasing consciousness of the early analysis of ailments. Furthermore, in the U.S., the count of hospitals is growing, with about 8,000 of these functioning as of 2023.

It is because of the rising incidence of cancer all over thew world, and increasing awareness of early diagnosis, the demand for medical X-ray film processor is on the rise. This trend will continue in the years to come as well.

Read More

Software had a Considerable Share in the Patient Referral Management Software Industry

The size of the patient referral management software market was USD 9,598.3 million in 2023, and it will power at a rate of 17.9% by the end of this decade, to touch USD 30,221.2 million by 2030.

To learn more about this report: https://bit.ly/4aHv5kv

The increasing elderly populace across numerous nations, government initiatives to boost healthcare systems to accept IT solutions, and incessant tech expansions are some of the major reasons that can be credited for the growth of the industry.

Moreover, precision in scheduling actions, competence in data management, streamlining of everyday processes, and development in the access to medical amenities are some of the recompences of this kind of software that would let the industry to uphold momentum.

More than a few ailments are common in old age. An effective referral system can support in upholding the needed degree of communication and coordination amongst the numerous levels of the healthcare system, for example secondary-care hospitals, main-care or local hospitals, and tertiary-care facilities.

The patient referral management software market share of the cloud-based category will be the larger in the years to come. It can be credited to the rising recognition of cloud-based solutions because of their negligeable capital spending for data security, hardware setup, deterrence of the loss of info, and enhanced scalability of the storing capacity. Health records and further critical data can be managed and stored online more easily by using cloud-based solutions.

Eventually, cloud deployment offers improved flexibility and cost-efficiency as opposed to on-premises disposition. Applications, software, and tools can be effortlessly combined with the cloud system, and therefore, the requirement for cloud-based solutions will be on the rise in the future.

It is because of the growing elderly population all over the world, the requirement for patient referral management software is on the rise. This trend will continue to grow in the years to come as well.

Read More

Hospitals are the Foremost Users of the Healthcare Equipment Rental

The total value of the healthcare equipment rental market was USD 59.1 billion in 2023, and it will power at a rate of 5.7% by the end of this decade, to touch USD 86.8 billion by 2030.

To learn more about this report: https://bit.ly/3vke2F9

The growth has a lot to do with the growing requirement for medical instruments and rising count of hospitals and clinics providing advanced care. Furthermore, the high rate of medical equipment and the tax reimbursements on renting it are contributing to the growth of the industry. The introduction of tech cutting-edge products, for example sling lifts, will power the healthcare equipment leasing actions further.

Durable medical equipment held a key share, of 35%, as it supports more and more use. The growing count of disabled and elderly individuals will power the requirement for mobility and other sorts of assistive instruments, which will contribute to the development of this category.

The homecare category will grow at a substantial rate in the years to come, credited to the thriving prevalence of numerous ailments, for example diabetes, which needs therapeutic devices, such as insulin pumps.

The increasing need for home healthcare devices and elderly care centers is among the most-significant drivers for the healthcare equipment rental market in this category. The category’s development is bolstered by the rising populace of the aging, which is particularly susceptible to diabetes and cardiac ailments.

North America is the leader of the pack, with USD 29.5 billion, in 2023. This is because of the high requirement for the cutting-edge products and the existence of numerous leasing service providers. Furthermore, the increasing device cost powers the spending on the acquisition of the state-of-the-art therapeutic apparatus, which can be resolved by renting the equipment.

Due to the growing demand for medical instruments all over the world, the demand for healthcare equipment rental is on the rise. This trend will continue in the years to come as well.

Read More

Accelerometer Medical Sensors Industry Will Advance at a 14.4% CAGR

The accelerometer medical sensors market was USD 4,111.5 million in 2023, which will rise to USD 10,442.9 million, advancing at a 14.4% compound annual growth rate, by 2030.

To learn more about this report: https://bit.ly/3tzwyc6

This growth is mainly driven by the rising need for nonstop monitoring of health; physiological sensors miniaturization; and enhanced functions, cost-effectiveness, and ease of operation of these devices.

Furthermore, this growth is also assisted by the surging populace with high disposable salaries, which suggests they can easily spend money on developed technologies.

The wearables category, on the basis of products, is the major contributor to the industry. This can be because it is employed for measuring different factors of health like blood pressure, heart rate, and carbon dioxide level. The measurement of such factors assists healthcare professionals as well as researchers in gaining responses and providing greater treatment.

The hospitals & clinics category, on the basis of end user, is the major contributor to the industry. This can be because of the speedy acceptance of developed technologies, easy treatment availability and affordability, the existence of experienced specialists in these healthcare facilities, and the large patient pool.

Furthermore, the existence of numerous hospitals and the rising healthcare spending in both developing and developed nations like China, the U.S., and the U.K., and various chronic illness-associated surgeries are conducted in hospitals, which boosts the expansion of this category.

The chronic illness & risk monitoring category, on the basis of application, is leading the accelerometer medical sensors market. This is primarily because of the rising occurrence of cancer, cardiovascular illnesses, and other illnesses. The key causes of these illnesses comprise smoking and tobacco consumption, unhealthy dietary habits, and obesity. 

Moreover, the wellness monitoring category will propel at the fastest compound annual growth rate in the years to come. This is primarily because of the monitoring or tracking of health care parameters in a digital setting using sensor-based devices, which assists in monitoring movement as well as intensity.

North America is the largest contributor to the industry, and it is likely to remain the largest, generating USD 1.8 billion in 2030. This can be mainly because of the well-established healthcare system, coupled with the high disposable salary in this continent.

APAC is likely to be a significant contributor to the industry in 2030. This will be mainly attributed to the increasing unhealthy lifestyle among people, the surging aging populace, the rising incidence of cardiovascular illnesses, and the growing acceptance of developed technologies.

It is because of the rise in awareness about health and fitness, the accelerometer medical sensors industry will continue to grow significantly in the years to come.

Read More

North America Is Dominating Pyrogen Test Market

Revenue of USD 1,406.4 million was generated in the global pyrogen test market for 2023, which is expected to grow at a compound annual growth rate of 7.3% over the period from 2024 to 2030 and reach USD 2,284.2 million. This growth of the market can be credited to the increasing acceptance of pyrogen testing within the biopharmaceutical sector.

To learn more about this report: https://bit.ly/3viQeS0

Furthermore, the rising development in the biotechnology and pharmaceutical industries along with the increasing count of new biologics research and introductions is projected to fuel the demand for these testing for making safe and better drugs.

Pyrogen testing is a vital step for each medication and therapeutics to make it safer and more effective. Surge in the count of cancer cases and hereditary illnesses, modified treatments attained benefits in the treatment of these diseases.

Tailored medicine has the benefit that it uses people’s hereditary profiles to aid in decision-making for the prevention, diagnosis, and treatment of illnesses. Therefore, patients and businesses are quickly accepting modified drugs. Furthermore, modified treatment-based methods to clinical and genomic features are becoming more popular among patients with cancer and immunologic sicknesses. Hence, the increasing need for modified drugs is one of the key reasons propelling the demand for pyrogen testing solutions.

In the North American region, the U.S. dominates the industry. This is mainly because of the existence of advanced healthcare infrastructure, augmented concentration on new drug growth, and the presence of key biotechnology and biopharmaceutical companies, like Pfizer Inc. and F. Hoffmann-La Roche AG, in the country.

Furthermore, Canada is also generating substantial revenue for the North American industry. This can be credited to the rising pharmaceutical and biotechnology sector, the rising awareness regarding the safety of medications, and the growing R&D activities in the country.

Read More